France· FR:63262400
LOQTORZI 240 mg, solution à diluer pour perfusion
A toripalimab product containing toripalimab, registered in France by TOPALLIANCE BIOSCIENCES EUROPE (IRLANDE). The same ATC class is registered in 12 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Toripalimab is registered in 12 of 19 countries.
Countries holding a registration under ATC L01FF13 (toripalimab), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 8 of them publish a price we can compare per daily dose
Toripalimab · ATC L01FF13
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- TORIPALIMAB
- Manufacturer
- TOPALLIANCE BIOSCIENCES EUROPE (IRLANDE)
- Country
- France (FR)
- ATC code
- L01FF13
- ATC class
- Toripalimab
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009551102241 flacon(s) en verre de 6 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Toripalimab in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsLOQTORZI 240 mg concentraat voor oplossing voor infusieTopalliance Biosciences Europe Limited
- United StatesLOQTORZICoherus Oncology, Inc.
- CzechiaLOQTORZITopalliance Biosciences Europe Limited, Dublin
- SpainLOQTORZI 240 MG CONCENTRADO PARA SOLUCION PARA PERFUSIONTopalliance Biosciences Europe Limited
- FinlandLOQTORZITopalliance Biosciences Europe Limited
- United KingdomLoqtorzi 240mg/6ml concentrate for solution for infusion vialsLEO Pharma
- IrelandLOQTORZI 240 mg concentrate for solution for infusionTopalliance Biosciences Europe Limited
- BelgiumLoqtorzi 240 mgTopalliance Biosciences Europe
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Loqtorzi
- Liechtenstein · Loqtorzi
- Norway · Loqtorzi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d7abfa94-ada7-4d7c-b248-dd363edea4f7 GET /v1/drugs/d7abfa94-ada7-4d7c-b248-dd363edea4f7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63262400",
"date_amm": "2024-09-19",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/24/1853",
"substance": "TORIPALIMAB",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution à diluer pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}See everything about toripalimab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.